Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学CRISPR Gene Editing, Cancer Therapy

Jennifer Doudna

PhD

🏢University of California, Berkeley🌐USA

Professor of Chemistry and Molecular & Cell Biology

98
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jennifer Doudna is a co-inventor of CRISPR-Cas9 gene editing technology and was awarded the Nobel Prize in Chemistry in 2020 alongside Emmanuelle Charpentier. Her laboratory at UC Berkeley pioneered the biochemical characterization of CRISPR-Cas9 and continues to develop next-generation genome editing platforms. Her work has transformative implications for cancer therapy including CAR-T cell engineering and oncogene correction. She founded the Innovative Genomics Institute to accelerate therapeutic applications of genome editing.

Share:

🧪Research Fields 研究领域

CRISPR-Cas9
genome editing
RNA biology
therapeutic gene editing
cancer gene therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Jennifer Doudna 的研究动态

Follow Jennifer Doudna's research updates

留下邮箱,当我们发布与 Jennifer Doudna(University of California, Berkeley)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment